glaxosmithkline update: influenza a (h1n1), page-8

Porta,
I agree, it's about time GSK dumped the Diskhaler. It's only taken 8 years since a published trial concluded,

"Our study shows that zanamivir treatment for elderly people with influenza is unlikely to be effective. Better delivery systems for inhalers should be used or developed."

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=26548




If only GSK had mentioned iv zanamivir. The supporters for iv peramavir think they have systemic treatment for hospitals sown up, but just like Tamiflu, it's H274Y prone, and will ultimately be useless too.

iv zanamivir could be used for all ages, and lead the way for injectable LANI.

GSK are financial wizards too.